STOCKS TELEGRAPH

Tag: HEPA

  • Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Early Morning Vibes: Top 4 Stocks To Buy Right Now

    On February 18, American stock indices ended in the red. The S&P 500 index fell 0.44% to 3914 points, the Dow Jones fell 0.38%, the NASDAQ fell 0.72%, losing more than 1.5% during the session. The reason for the correction was the data on the growth in the number of applications for unemployment benefits, as well as the flow of capital into cyclical sectors. Thus, the consumer goods segment traded better than the market, ending the day with a result of + 0.14%. The energy sector corrected by 2.27%.

    Company news

    Software developer Twilio (TWLO: + 7.7%) posted strong quarterly results, with revenue growth exceeding expectations.

    Walmart’s comparable sales (WMT: -6.5%) were better than the consensus, but investors were disappointed by the weak EPS performance and the forecast that the retailer’s capex will increase from $ 10 billion to $ 14 billion this year.

    Revenue and EBITDA of lithium supplier Albemarle (ALB: -10.2%) exceeded investor expectations, but the company’s forecasts were not strong enough.

    Today, global stock markets are showing mixed dynamics. Investors continue to assess the potential impact of rising bond yields on the stock market. The 10-year Treasury yield climbed to the February 2020 level. From the point of view of corporate finance, in this situation, the discount rate increases, which ultimately reduces the fair value of the shares. At the same time, an increase in the yield of government bonds reflects an improvement in economic prospects, so there is no consensus among the investment community regarding the impact of this factor on the market.

    The current consensus on the fiscal stimulus package suggests that it will be approved in mid-March in the amount of about $ 1.5 trillion. Moreover, after the adoption of this package, all attention will be focused on infrastructure government spending, the project of which will be presented next month. Their estimated volume is $ 2 trillion. Rumors regarding this bill are already beginning to influence the market.

    The Freedom Finance Sentiment Index climbed to 80 out of 100. The indicator reflects market participants’ hope for a global economic recovery in 2021. Concerns about the negative impact of the coronavirus pandemic are gradually diminishing thanks to the prospect of mass vaccinations.

    Technically, the S&P 500 is still in an uptrend, the upper bound of which limits the upside potential of the broad market index. The previous trading session did not change the overall picture too much. In the short term, correction or consolidation is likely, as a bearish divergence is being formed on the RSI indicator.

    Today Top Movers

    Zynga Inc. (ZNGA) stock soared 1.16% to $12.24 in pre-market trading.‎ ZNGA is a global leader in interactive entertainment Games recently announced Star Wars: Hunters, a competitive arena combat game.

    Cuentas Inc. (NASDAQ: CUEN) shares are trading up 46.01% at $5.49 at the time of writing. ‎CUEN is a leading FinTech provider of mobile banking and payment solutions focused on Hispanic and Latino communities. ‎

    ‎Mmtec Inc. (MTC) grew over 80.31% at $7.05 in pre-market trading today. MTC is a company that develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements.

    ‎Citius Pharmaceuticals Inc. (CTXR), a Biotechnology company, rose about 26.92% at $1.98 in pre-market trading Friday after declaring a $76.5 million registered direct offering priced at-the-market under Nasdaq Rules.‎

    Top Upgrades & Downgrades

    Roth Capital turned bullish on Coeur Mining Inc. (CDE), upgrading the stock to “Buy” and assigning a $10.0 price target, representing a potential upside of 19.19% from Thursday’s close. 

    Sabre Corporation (SABR) has won the favor of Deutsche Bank’s equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $17.0, suggesting 33.65% additional upside for the stock. 

    Everbridge Inc. (EVBG) received an upgrade from analysts at JP Morgan, who also set their one-year price target on the stock to $200.0. They changed their rating on EVBG to Overweight from Neutral in a recently issued research note. 

    Earlier Friday Mizuho reduced its rating on Sunoco LP (SUN) stock to Neutral from Buy and assigned the price target to $33.0. With shares trading at around $30.58, the Wall Street firm thinks Sunoco LP’s stock could add than 7.63%. 

    Deutsche Bank analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for eHealth Inc. (EHTH) has been changed to Hold from Buy and the new price target is set at $63.0. 

    Analysts at JP Morgan downgraded The Kraft Heinz Company (KHC)’s stock to Neutral from Overweight Friday.

    Latest Insider Activity

    Twitter Inc. (TWTR) Chief Legal Officer Gadde Vijaya announced the sale of shares taking place on Feb 16 at $72.03 for some 14,940 shares. The total came to more than $1.08 million. 

    Inovio Pharmaceuticals Inc. (INO) Director BENITO SIMON X sold on Feb 16 a total of 51,650 shares at $14.68 on average. The insider’s sale generated proceeds of almost $29360. 

    Hepion Pharmaceuticals Inc. (HEPA) Chief Financial Officer Cavan John T declared the purchase of shares taking place on Feb 18 at $2.00 for some 10,000 shares. The transaction amount was around $20000. 

    United States Steel Corporation (X) Director Atkinson Tracy A bought on Feb 16 a total 17,177 shares at $17.07 on average. The purchase cost the insider an estimated $25,059.

    Important Earnings

    Top US earnings releases scheduled for today include MoneyGram International Inc. (NASDAQ: MGI). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.08 per share from revenues of $326.62M in the three-month period. 

    Analysts expect Deere & Company (NYSE: DE) to report a net income (adjusted) of $2.16 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Jan 2021 is predicted to come in at $7.21B. 

    Enerplus Corporation (ERF), due to announce earnings before the market opens today, is expected to report earnings of $0.22 per share from revenues of $241.79M recently concluded three-month period.

  • 23 Stocks Making Sharp Moves in Pre Market Session

    23 Stocks Making Sharp Moves in Pre Market Session

    ‎Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-‎market ‎trading after reporting that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy.‎

    ‎Tenax Therapeutics Inc. (NASDAQ: TENX) shares are trading down -7.07% at $1.84 ‎at ‎the time of writing. Company’s 52-week ranged between $0.25 to $2.68.‎

    ‎Ideanomics Inc. (IDEX) stock soared 2.87% to $2.15 in the pre-market trading. ‎The ‎company recently revealed that its Mobile Energy Global (“MEG”) and its contracting entity ‎Qingdao ‎Chengyang Medici have signed an agreement with Meihao Chuxing, a joint venture between ‎BYD and ‎Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Oxbridge Re Holdings Limited (OXBR) stock moved down -6.83 percent to $1.91 ‎in ‎the pre-market trading.‎

    ‎Guardion Health Sciences Inc. (NASDAQ: GHSI) shares are trading up 12.48% ‎at ‎‎$0.4289 at the time of writing. The firm lately declared the appointment of seasoned ‎nutritional ‎products industry leader Bret Scholtes as President and Chief Executive Officer. Company’s ‎‎52-week ‎ranged between $0.17 to $0.74.‎

    ‎Gevo Inc. (GEVO) is down more than -4.76% at $4.4 in pre-market ‎hours ‎Wednesday December 30, 2020. The stock had dropped over -4.15% to $4.62 in the last ‎trading ‎session.‎

    ‎Universal Security Instruments Inc. (UUU) stock moved up 5.0 percent to $5.25 ‎in ‎the pre-market trading following its statement regarding recent market activity in the ‎Company’s ‎stock.‎

    ‎Marathon Patent Group Inc. (MARA) gained over 10.03% at $12.94 in pre-‎market ‎trading Wednesday December 30, 2020. The company recently reported that it has entered ‎into a ‎contract with Bitmain to purchase 70,000 Antminer S-19 ASIC miners.‎

    Before the trading started on December 30, 2020, Ocugen Inc. (OCGN) is down -‎‎‎7.83% to reach $2.0. It has been trading in a 52-week range of $0.17 to $3.05.‎

    Before the trading started on December 30, 2020, Moderna Inc. (MRNA) is ‎up ‎‎3.59% to reach $118.5 following the declaration from the company that the it is engaged in ‎discussions ‎with the government of South Korea to potentially provide 40 million or more doses of the ‎Moderna ‎COVID-19 Vaccine to support South Korea’s aim of providing vaccines to the public as soon as ‎possible. ‎It has been trading in a 52-week range of $17.68 to $178.50.‎

    ‎Riot Blockchain Inc. (RIOT) stock soared 6.02% to $16.74 in the pre-market trading.‎

    ‎Technical Communications Corporation (NASDAQ: TCCO) shares are trading down -‎‎‎16.78% at $4.76 at the time of writing after declaring its results for the fiscal year ended September ‎‎26, ‎‎2020. Company’s 52-week ranged between $1.72 to $7.00.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) is up more than 2.21% at $0.6695 ‎in ‎pre-market hours Wednesday December 30, 2020. The stock had dropped over -6.16% to $0.65 in ‎the ‎last trading session.‎

    ‎AstraZeneca PLC (AZN) gained over 2.26% at $51.03 in pre-market ‎trading ‎Wednesday December 30, 2020 after receiving approval of its coronavirus vaccine in U.K.‎

    ‎New Concept Energy Inc. (AMEX: GBR) shares are trading down -14.75% at $2.08 ‎at ‎the time of writing. Company’s 52-week ranged between $0.55 to $2.19.‎

    ‎Moleculin Biotech Inc. (MBRX) stock plunged -1.67% to $0.8279 in the pre-‎market ‎trading after declaring that that the US Food and Drug Administration (FDA) has granted ‎Orphan Drug ‎Designation (ODD) to Annamycin for treatment of soft tissue sarcomas.‎

    ‎MoSys Inc. (MOSY), a Semiconductors company, dropped about -13.22% at $2.1 ‎in ‎pre-market trading Wednesday.‎

    Before the trading started on December 30, 2020, Greenpro Capital Corp. (GRNQ) ‎is ‎down -2.15% to reach $1.82. The company lately revealed that it intends to set up a Bitcoin ‎‎($BTC) ‎Fund for investment. It has been trading in a 52-week range of $0.21 to $3.12.‎

    ‎Nxt-ID Inc. (NXTD) gained over 9.92% at $1.44 in pre-market trading ‎Wednesday ‎December 30, 2020.‎

    ‎Hepion Pharmaceuticals Inc. (HEPA) gained over 50.0% at $3.12 in pre-‎market ‎trading Wednesday December 30, 2020 after declaring positive top line data for low dose ‎CRV431 in ‎Phase 2a ‘AMBITION’ clinical trial for treatment of Advanced NASH.‎

    ‎XPeng Inc. (XPEV) is up more than 3.13% at $42.85 in pre-market hours ‎Wednesday ‎December 30, 2020. The stock had jumped over 9.31% to $41.55 in the last trading session.‎

    ‎BioNTech SE (BNTX) is up more than 3.5% at $91.37 in pre-market hours ‎Wednesday ‎December 30, 2020 following declaration from the financial magazine Caixin that Shanghai ‎Fosun ‎Pharmaceutical Group will set up a joint venture with BioNTech to produce COVID-19 vaccines in ‎China. ‎The stock had jumped over 0.19% to $88.28 in the last trading session.‎

    Before the trading started on December 30, 2020, Bit Digital Inc. (BTBT) is up ‎‎14.58% ‎to reach $12.1. It has been trading in a 52-week range of $0.28 to $12.45.‎

  • Market Movers: What changed for these 37 stocks while you were sleeping

    Market Movers: What changed for these 37 stocks while you were sleeping

    Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will begin a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China. Company’s 52-week ranged between $0.53 to $3.10. Analysts have a consensus price target of $7.75.
    SELLAS Life Sciences Group Inc. (SLS) stock plunged -24.18% to $13.39 in the pre-market trading. The most recent rating by Oppenheimer, on November 01, 2018, is an Outperform.
    Veru Inc. (VERU) tumbled over -11.89% at $5.26 in pre-market trading today. The firm recently declared that it has exclusively licensed phase 3 clinical stage targeted therapy for endocrine resistant metastatic breast cancer.
    Before the trading started on December 11, 2020, Professional Diversity Network Inc. (IPDN) is down -25.0% to reach $1.53. It has been trading in a 52-week range of $0.76 to $3.98.
    Neos Therapeutics Inc. (NEOS), a Drug Manufacturers – Specialty & Generic company, dropped about -16.36% at $0.6832 in pre-market trading Friday after announcing definitive merger agreement with Aytu BioScience, pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
    Callon Petroleum Company (CPE) is down more than -0.53% at $15.0 in pre-market hours Friday December 11, 2020. The stock had jumped over 7.71% to $15.08 in the last trading session.
    C3.ai Inc. (AI) stock moved down -5.38 percent to $123.0 in the pre-market trading. The company lately declared the pricing of its initial public offering of 15,500,000 shares of its Class A common stock at a price of $42.00 per share.
    Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) shares are trading up 2.21% at $1.85 at the time of writing. Company’s 52-week ranged between $1.00 to $6.90. Analysts have a consensus price target of $14.
    Regulus Therapeutics Inc. (RGLS) stock plunged -9.92% to $1.09 in the pre-market trading. The healthcare company revealed closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is a Neutral.
    Range Resources Corporation (RRC) stock plunged -4.79% to $7.35 in the pre-market trading. The most recent rating by Stephens, on November 16, 2020, is an Overweight.
    Zedge Inc. (AMEX: ZDGE) shares are trading up 23.7% at $6.68 at the time of writing after reporting first fiscal quarter revenue growth of 85% and record overall quarterly financial results. Company’s 52-week ranged between $0.66 to $4.70. Analysts have a consensus price target of $3.
    Hennessy Capital Acquisition Corp. IV (HCAC), a Shell Companies company, dropped about -5.82% at $20.72 in pre-market trading Friday.
    Editas Medicine Inc. (EDIT) grew over 0.84% at $67.4 in pre-market trading today. The company recently publicized submission of IND application for EDIT-301 with the FDA.
    Greenwich LifeSciences Inc. (GLSI) is down more than -9.3% at $65.5 in pre-market hours Friday December 11, 2020 following the today’s announcement of poster presentation on its GP2 phase III clinical trial design for recurring breast cancer. The stock had jumped over 26.48% to $72.22 in the last trading session.
    Silver Spike Acquisition Corp. (SSPK) is down more than -2.78% at $14.0 in pre-market hours Friday December 11, 2020. The stock had jumped over 37.27% to $14.40 in the last trading session.
    Biocept Inc. (BIOC) stock plunged -3.07% to $5.68 in the pre-market trading after declaring results from a prospective study showing Target Selector™ was highly accurate in monitoring HER2 alterations in patients with metastatic breast cancer. The most recent rating by Chardan Capital Markets, on November 14, 2017, is a Buy.
    W&T Offshore Inc. (NYSE: WTI) shares are trading down -6.02% at $2.5 at the time of writing following the firm provided an operational update regarding fourth quarter 2020 production. Company’s 52-week ranged between $1.07 to $6.10.
    Before the trading started on December 11, 2020, Platinum Group Metals Ltd. (PLG) is up 1.93% to reach $5.27. It has been trading in a 52-week range of $0.86 to $5.20.
    Aytu BioScience Inc. (AYTU), a Biotechnology company, dropped about -24.72% at $6.12 in pre-market trading Friday after the company and Neos Therapeutics declared definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
    Torchlight Energy Resources Inc. (TRCH) stock soared 13.78% to $0.7226 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.
    Before the trading started on December 11, 2020, Energy Fuels Inc. (UUUU) is up 1.64% to reach $3.1 following the announcement from the company that that its President and CEO Mark S. Chalmers will be presenting live at the 13th Annual LD Micro Main Event investor conference on Monday, December 14, 2020 at 11:40 AM (EST). It has been trading in a 52-week range of $0.78 to $2.99.
    Ashford Hospitality Trust Inc. (NYSE: AHT) shares are trading up 8.04% at $4.3 at the time of writing. Company’s 52-week ranged between $1.27 to $29.44.
    ClearOne Inc. (CLRO) stock plunged -7.2% to $2.45 in the pre-market trading after declaring that it has appointed Chromasound PLC, based in Budapest, Hungary, as its newest distribution partner. The most recent rating by Singular Research, on August 16, 2018, is a Buy – long-term.
    ReWalk Robotics Ltd. (NASDAQ: RWLK) shares are trading up 3.7% at $1.4 at the time of writing after revealing a contract with a German private health insurance company to allow all eligible beneficiaries with spinal cord injury (SCIs) to apply for the procurement of a ReWalk 6.0 exoskeleton system. Company’s 52-week ranged between $0.41 to $2.71. Analysts have a consensus price target of $1.50.
    Progenity Inc. (PROG) grew over 9.32% at $4.34 in pre-market trading today. The firm recently reported closing of the convertible senior notes offering and partial exercise of the Initial purchaser’s option to purchase additional notes.
    Boxlight Corporation (BOXL) is down more than -7.69% at $1.8 in pre-market hours Friday December 11, 2020. The stock had jumped over 17.47% to $1.95 in the last trading session.
    Lemonade Inc. (LMND), a Insurance – Property & Casualty company, rose about 0.7% at $100.4 in pre-market trading Friday. The company recently declared that residents of France can now get renters insurance instantly, anytime, and from any device – as well as file claims and get paid in seconds through the Lemonade app.
    ObsEva SA (OBSV) lost over -2.54% at $2.3 in pre-market trading Friday December 11, 2020 after announcing topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy menstrual bleeding due to uterine fibroids.
    Amplify Energy Corp. (AMPY) is down more than -27.33% at $1.09 in pre-market hours Friday December 11, 2020 following the commencement of an underwritten public offering of 8,548,485 shares of its common stock by certain of its stockholders which are affiliates of Fir Tree Capital Management L.P. The stock had jumped over 11.94% to $1.50 in the last trading session.
    Before the trading started on December 11, 2020, Hoth Therapeutics Inc. (HOTH) is up 0.54% to reach $1.85 after the firm revealed that it has received approval to commence phase 1b clinical trial of BioLexa for the treatment of Atopic Dermatitis in humans. It has been trading in a 52-week range of $1.60 to $7.25.
    RMG Acquisition Corp. (RMG) grew over 6.6% at $22.29 in pre-market trading today after declaring stockholder meeting Date of December 28, 2020.
    Marathon Patent Group Inc. (MARA) is down more than -10.34% at $4.68 in pre-market hours Friday December 11, 2020. The company recently stated that it has entered into a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners. The stock had jumped over 9.21% to $5.22 in the last trading session.
    Before the trading started on December 11, 2020, Inseego Corp. (INSG) is up 7.26% to reach $13.15. The firm today reported that the it is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. It has been trading in a 52-week range of $3.91 to $15.25.
    Entera Bio Ltd. (ENTX) tumbled over -7.56% at $1.1 in pre-market trading today after revealing FDA approval of IND application for EB613 – an oral human Parathyroid Hormone (1-34) for the treatment of Osteoporosis.
    OncoCyte Corporation (OCX) stock moved up 3.23 percent to $2.24 in the pre-market trading. The firm recently reported that it will host a key opinion leader (KOL) call on the Company’s proprietary DetermaRx™ and DetermaIO™ molecular tests for cancer treatment selection on Tuesday, December 15, 2020 at 11:00am Eastern Time.
    ZK International Group Co. Ltd. (ZKIN) lost over -4.98% at $2.1 in pre-market trading Friday December 11, 2020 after declaring that it signed a letter of intent with Tuopeng Industrial, a prominent construction and real estate company.
    Before the trading started on December 11, 2020, Arbutus Biopharma Corporation (ABUS) is up 15.8% to reach $4.25. It has been trading in a 52-week range of $0.88 to $9.02 following the declaration of additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.

  • Don’t Miss these 15 Biotechnology Value Stocks

    Biotech and Major Pharmaceuticals are back in the news with the Covid-19 Pandemic. Life science investors basically endorse developments that might decide the human race’s future, but what would invest in ‘cures’ mean from a cash flow point of view?
    On Thursday, a panel of independent health professionals voted 17-4 in support of the Food and Drug Administration(FDA), providing emergency permission to the applicant for the COVID-19 vaccine from BioNTech and Pfizer Inc.
    In other news Gilead Sciences Inc (GILD) revealed that it would buy MYR GmbH in cash for roughly EUR 1.15 billion ($1.39 billion), granting it access to the German biotech company’s therapy for extreme viral hepatitis.
    In yesterday’s trading session, the following stocks were the major key players.

    Immutep Limited (NASDAQ:IMMP) shares were trading up 163.43% at $5.69 at the time of writing on Thursday after declaring that its Chinese partner, EOC Pharma will commence a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China.

    Immutep Limited (NASDAQ:IMMP) share price went from a low point around $0.53 to briefly over $3.10 in past 52 weeks, though shares have since pulled back to $5.69. IMMP market cap has remained high, hitting $280.46M at the time of writing.

    If we look at the recent analyst rating IMMP, B. Riley FBR initiated coverage on IMMP shares with a Buy rating.

    TG Therapeutics Inc. (TGTX) stock soar by 40.85% to $41.72 after reportingpositive topline results from the ULTIMATE I & II Phase 3 studies evaluating Ublituximab Monotherapy for the treatment of patients with multiple sclerosis. The most recent rating by JP Morgan, on September 01, 2020, is at an Overweight.

    Heat Biologics Inc. (HTBX) last closed at $0.93, in a 52-week range of $0.19 to $4.30.

    Sangamo Therapeutics Inc. (NASDAQ:SGMO) Shares headed rising, higher as much as 52.98%. Pfizer Inc. (PFE) and Sangamo Therapeutics, Inc. (SGMO), on December 7, 2020 declared updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec (SB-525 or PF-07055480), an investigational gene therapy for patients with severe hemophilia A. The most recent rating by BofA Securities, on September 08, 2020, is at a Buy.

    Entera Bio Ltd. (NASDAQ:ENTX) rose 8.18% after gaining more than $0.09 on Thursday following the firm revealed FDA approval of IND application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the treatment of Osteoporosis.

    Aytu BioScience Inc. (AYTU) last closed at $8.13, in a 52-week range of $3.35 to $29.90 after announcing definitive merger agreement with Neos Therapeutics, creating a combined $100M revenuespecialty pharmaceutical company.

    Amarin Corporation plc (AMRN) stock soar by 8.04% to $4.97. The most recent rating by JP Morgan, on September 29, 2020, is at a Neutral.

    Editas Medicine Inc. (NASDAQ:EDIT) Shares headed rising, higher as much as 32.15% following an announcement from the company that it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1/2 clinical trial of EDIT-301. The most recent rating by Wells Fargo, on December 10, 2020, is at an Overweight.

    Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) rose 9.04% after gaining more than $0.15 on Thursday.

    Akebia Therapeutics Inc. (AKBA) last closed at $2.95, in a 52-week range of $2.09 to $13.71. The firm recently revealed the latest scheduled program of AkebiaShares, a peer-to-peer educational series for the kidney community.

    BioCryst Pharmaceuticals Inc. (BCRX) stock soar by 5.37% to $7.65. The company recently announced transactions with Royalty Pharma (RPRX) and Athyrium Capital Management, LP, totaling $325 million in funding for BioCryst, with $250 million available at closing, to support the launch of ORLADEYO™ (berotralstat) in hereditary angioedema (HAE) and the development of its oral Factor D inhibitor, BCX9930. The most recent rating by JP Morgan, on September 29, 2020, is at an Overweight.

    Acasti Pharma Inc. (NASDAQ:ACST) Shares headed rising, higher as much as 1.70%. The company on November 16, 2020 released its operating and financial results for the second quarter of fiscal 2021 ended September 30, 2020. The most recent rating by Oppenheimer, on September 01, 2020, is at a Perform.

    Ocugen Inc. (NASDAQ:OCGN) fall -1.79% after losing more than -$0.01 on Thursday after reporting that it will postpone its 2020 Annual Meeting of Stockholders to December 23, 2020.

    Inovio Pharmaceuticals Inc. (INO) last closed at $11.36, in a 52-week range of $2.42 to $33.79. The firm recently revealedthe successful dosing of its first subject in its Phase 2 clinical trial for COVID-19 DNA vaccine candidate, INO-4800, in China. Analysts have a consensus price target of $13.71.

    Cellectar Biosciences Inc. (CLRB) stock soar by 3.47% to $2.09. The most recent rating by Oppenheimer, on July 01, 2020, is at an Outperform.

  • Early Morning Vibes: 3 Best Performing Stocks Under $3

    Early Morning Vibes: 3 Best Performing Stocks Under $3

    On December 8, American stock exchanges closed at historic highs. The S&P 500 Index climbed 0.28% to 3702 points, the Dow Jones added 0.35%, the NASDAQ rose 0.5%. The purchases spurred hope for fiscal stimulus, as well as the start of the UK vaccine distribution. The health and energy sectors were the top gains, rising 0.73% and 1.57%, respectively. The real estate segment turned out to be an outsider, losing 0.5%.

    Corporate news

    Tesla (TSLA: + 1.3%) announced a $ 5 billion additional share issue.

    Productivity software maker Smartsheet (SMAR: + 11%) reported strong quarterly results and improved management forecasts.

    Apparel retailer Stitch Fix (SFIX: + 39%) posted a good quarterly report, with a pleasant surprise for investors the company’s profit at a consensus loss.

    Today, world stock markets are showing mostly positive dynamics. The likelihood of accepting an economic aid package is increasing. The day before, Treasury Secretary Stephen Mnuchin presented House Speaker Nancy Pelosi a $ 916 billion economic support bill. Unlike the bipartisan stimulus package last week, the bill provides for a one-time payment of $ 600 to each citizen instead of $ 300 weekly in addition to the unemployment. Republican leaders have already expressed support for Mnuchin’s bill. We believe that the congressmen have not yet been so close to a compromise in the past few months, and this is encouraging.

    Another supportive factor was a report released by the FDA that the Pfizer / BioNTech anticancer vaccine is completely safe and highly effective. The probability of its approval on December 10 is close to 100%, and on the 11th, the distribution of the drug in the United States may begin. We estimate the risk that the pharmaceutical giant will face difficulties in mass production of the vaccine as minimal, although not zero.

    Today Top Movers Under $3

    Cinedigm Corp (CIDM) is up 50.35% at $1.30 in early morning on Wednesday after

    Spherex revealed a strategic alliance with Cinedigm (NASDAQ: CIDM) to drive Cinedigm’s global growth.

    Usio Inc (USIO) is up 38.80% in Wednesday’s premarket session after reporting that it has entered into a non-binding Letter of Intent (LOI) to acquire the assets of Information Management Solutions, LLC (IMS).

    Recon Technology Ltd (RCON) was taking the aerial route in the after-market session as it surged 95.8% to $2.82, after a China-based independent solutions integrator in the oilfield service and environmental protection, electric power, and coal chemical industries, today announced its financial results for the fiscal year 2020.

    Top Upgrades & Downgrades

    JP Morgan turned bullish on Array Technologies Inc. (ARRY), upgrading the stock to “Overweight” and assigning a $41.0 price target.

    Community Trust Bancorp Inc. (CTBI) has won the favor of Piper Sandler’s equity research team. The firm upgraded the shares from Neutral to Overweight.

    Earlier Wednesday JP Morgan reduced its rating on Bloom Energy Corporation (BE) stock to Neutral from Overweight and assigned the price target to $26.0. With shares trading at around $30.59, the Wall Street firm thinks Bloom Energy Corporation’s stock could decline more than -62.5%.

    DZ Bank analysts reduced their investment ratings, saying in research reports covered by the media that its rating for American Express Company (AXP) has been changed to Hold from Buy and the new price target is set at $128.0.

    Analysts at KeyBanc downgraded Talos Energy Inc. (TALO)‘s stock to Sector Weight from Overweight Wednesday.

    Latest Insider Activity

    Freeport-McMoRan Inc. (FCX) Vice Chairman, President & CEO ADKERSON RICHARD C announced the sale of shares taking place on Dec 04 at $25.17 for some 467,887 shares. The total came to more than $11.78 million.

    Discovery Inc. (DISCA) Director LOWE KENNETH W sold on Dec 04 a total 1,202,403 shares at $25.22 on average. The insider’s sale generated proceeds of almost $2.32 million.

    Regulus Therapeutics Inc. (RGLS) 10% Owner Sonsini Peter W. declared the purchase of shares taking place on Dec 04 at $0.62 for some 4,398,602 shares. The transaction amount was around $2.74 million.

    Hepion Pharmaceuticals Inc. (HEPA) CEO and Director Foster Robert T bought on Dec 08 a total 25,259 shares at $1.58 on average. The purchase cost the insider an estimated $39,418.

    Earnings To Watch Today

    Top US earnings releases scheduled for today include Asana Inc. (NYSE:ASAN). It will announce its Oct 2020 financial results. The company is expected to report earnings of -$0.37 per share from revenues of $54.14M in the three-month period.

    Analysts expect Mesa Air Group Inc. (NASDAQ:MESA) to report a net income (adjusted) of -$0.02 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2020 is predicted to come in at $92.95M.

    Adobe Inc. (ADBE), due to announce earnings after the market closes today, is expected to report earnings of $2.66 per share from revenues of $3.36B recently concluded three-month period.